New Research Study by the Mayo Clinic Finds Sedation-Free TNE With EndoSheath(R) Technology May Provide an Effective Alternat...
December 29 2014 - 7:30AM
A new peer-reviewed research study published in the American
Journal of Gastroenterology concludes sedation-free transnasal
esophagoscopy (TNE) may provide an effective alternative strategy
to conventional sedated esophagogastroduodenoscopy (EGD) for
esophageal assessment and Barrett's Esophagus (BE) screening for
patients. The research trial was conducted by gastroenterologists
at the Mayo Clinic utilizing the Vision Sciences® Transnasal
Esophagoscope with EndoSheath Technology and evaluated over 200
patients in both a clinic setting and in the community as part of
the health system's mobile research program.
"This research is extremely timely given the recent events
surrounding conventional EGD and the use of anesthesia," states
Howard Zauberman, President and Chief Executive Officer of
Vision-Sciences. "Healthcare providers can feel confident offering
their patients an alternative that will allow them to provide
procedures that do not use sedation while still providing top rate
diagnostic care."
The study, "A Randomized Comparative Effectiveness Trial of
Novel Endoscopic Techniques and Approaches for Barrett's Esophagus
Screening in the Community," goes on to detail the EndoSheath TNE
system and the technology's portable and disposable nature as
"effective and acceptable." EndoSheath technology utilizes a
sterile, disposable sheath that covers the endoscope and completely
isolates it from patient contact, obviating the need for time
consuming conventional decontamination and reprocessing
procedures.
"We feel our EndoSheath Technology provides a win-win for
healthcare facilities and patients; a sedation-free alternative to
conventional endoscopes for the patient while offering a portable,
efficient, cost cutting solution that allows for an increase in
patient throughput for the healthcare provider," adds Howard
Zauberman.
A few important highlights to note in the report:
- Mobile van and clinic TNE had comparable clinical effectiveness
with similar participation rates and safety profile to the standard
EGD, upper endoscopy procedure
- TNE with EndoSheath Technology allowed for shorter evaluation
and patient recovery times
- Sedation-free TNE with EndoSheath Technology may provide an
effective alternative strategy to standard upper endoscopy
procedures in esophageal assessments and screening for Barrett's
esophagus (BE)
- Participation rates were numerically higher in sedation-free
TNE compared with EGD
- 80% of TNE subjects were willing to undergo the procedure again
in the future
- Mobile van screening for BE and esophageal adenocarcinoma (EAC)
may be an effective alternative to hospital or clinic-based
techniques
Mr. Zauberman is available for in-person meetings or phone
interviews about this subject. Please contact Mitch Kayden at (845)
709-5607 or mkayden@onitdigital.com for more information and to set
up an interview.
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and
markets products for flexible endoscopy. The Company's unique
product lines feature a streamlined visualization system and
proprietary sterile disposable microbial barrier, known as
EndoSheath® technology, providing users with efficient and cost
effective endoscope turnover while enhancing patient safety.
Information about Vision-Sciences' products is available at
www.visionsciences.com.
Vision-Sciences owns the registered trademarks Vision Sciences®,
EndoSheath®, EndoWipe®, Slide-On®, and The Vision System®.
CONTACT: Mitch Kayden
(845) 709-5607
mkayden@onitdigital.com
Cognyte Software (NASDAQ:CGNT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cognyte Software (NASDAQ:CGNT)
Historical Stock Chart
From Apr 2023 to Apr 2024